Reduction in RNA levels rather than retardation of translation is responsible for the inhibition of major histocompatibility complex class I antigen presentation by the glutamic acid-rich repeat of herpesvirus saimiri open reading frame 73

Journal of Virology

Volumn 83, Issue 1, 2009, Pages 273-282

  Gao, Jiayu ^a,c   Coulson, Judy M ^a   Whitehouse, Adrian ^b   Blake, Neil ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF EAST LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; RNA; HLA ANTIGEN CLASS 1; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; GENE DELETION; HERPES VIRUS SAIMIRI; HUMAN; HUMAN CELL; INHIBITION KINETICS; MOLECULAR RECOGNITION; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN STABILITY; REDUCTION; RNA TRANSLATION; STEADY STATE; AMINO ACID SEQUENCE; BIOSYNTHESIS; CELL LINE; GENETICS; IMMUNOLOGY;

HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8; SAIMIRI; SAIMIRIINE HERPESVIRUS 2;

CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; HERPESVIRUS 2, SAIMIRIINE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; REPETITIVE SEQUENCES, AMINO ACID; RNA, MESSENGER; RNA, VIRAL; VIRAL PROTEINS;

EID: 58149399389     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01532-08     Document Type: Article

References (50)

1. Albrecht, J.-C. 2000. Primary structure of the herpesvirus ateles genome. J. Virol. 74:1033-1037.
2. Albrecht, J.-C., J. Nicholas, D. Biller, K. R. Cameron, B. Biesinger, C. Newman, S. Wittman, M. A. Craxton, H. Coleman, B. Fleckenstein, and R. W. Honess. 1992. Primary structure of the herpesvirus saimiri genome. J. Virol. 66:5047-5058.
3. Baer, R., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, T. J. Gibson, G. Hatfull, G. S. Hudson, S. C. Satchwell, C. Seguin, P. S. Tufnell, and B. G. Barrell. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-211.
4. Ballestas, M. E., and K. M. Kaye. 2001. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates epsiome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA. J. Virol. 75:3250-3258.
5. Ballestas, M. E., P. A. Chatis, and K. M. Kaye. 1999. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284:641-644.
6. Barbera, A. J., J. V. Chodaparambil, B. Kelley-Clarke, V. Joukov, J. C. Walter, K. Luger, and K. M. Kaye. 2006. The nucleosomal surface as a docking system for Kaposi's sarcoma herpesvirus LANA. Science 311:856-861.
7. Bennett, N. J., J. S. May, and P. Stevenson. 2005. Gamma-herpesvirus latency requires T cell evasion during episome maintenance. PLoS Biol. 3:638-649.
8. Burnside, K. L., J. T. Ryan, H. Bielefeldt-Ohmann, A. G. Bruce, M. E. Thouless, C.-C. Tsai, and T. M. Rose. 2006. RFHVMn ORF73 is structurally related to the KSHV ORF73 latency-associated nuclear antigen (LANA) and is expressed retroperitoneal fibromatosis (RF) tumor cells. Virology 354:103-115.
9. Calderwood, M. A., K. T. Hall, D. A. Matthews, and A. Whitehouse. 2004. The herpesvirus saimiri ORF73 gene product interacts with host-cell mitotic chromosomes and self-associates via its C terminus. J. Gen. Virol. 85:147-153.
10. Calderwood, M., R. E. White, R. A. Griffiths, and A. Whitehouse. 2005. Open reading frame 73 is required for herpesvirus saimiri A11-S4 episomal persistence. J. Gen. Virol. 86:2703-2708.
11. Chang, Y. P., P. S. Moore, S. J. Talbot, C. H. Boshoff, T. Zarkowska, K. Godden, H. Paterson, R. A. Weiss, and S. Mittnacht. 1996. Cyclin encoded by KS herpesvirus. Nature 382:410.
12. Cristillo, A. D., J. R. Mortimer, I. H. Barratte, T. P. Lillicrap, and D. R. Forsdyke. 2001. Double-stranded RNA as a not-self alarm signal: to evade, most viruses purine-load their RNAs but some (HTLV-1, Epstein-Barr) pyrmidine-load. J. Theor. Biol. 208:475-491.
13. Daskalogianni, C., S. Apcher, M. M., Candeias, N. Naski, F. Calvo, and R. Fahraeus. 29 August 2008, posting date. GLY-ALA repeats induce position and substrate specific regulation of 26S proteasome-dependent partial processing. J. Biol. Chem. doi:10.1074/jbc.M803290200.
14. Ensser, A., M. Thurau, S. Wittmann, and H. Fickenscher. 2003. The genome of herpesvirus saimiri C488 which is capable of transforming human T cells. Virology 314:471-487.
15. Ensser, A., R. Pflanz, and B. Fleckenstein. 1997. Primary structure of the alcelaphine herpesvirus 1 genome. J. Virol. 71:6517-6525.
16. Falk, K., J. W. Gratama, M. Rowe, J. Z. Zou, F. Khanim, L. S. Young, M. A. Oosterveer, and I. Ernberg. 1995. The role of repetitive DNA sequences in the size variation of Epstein-Barr virus (EBV) nuclear antigens, and the identification of different EBV isolates using RFLP and PCR analysis. J. Gen. Virol. 76:779-790.
17. Fickenscher, H., and B. Fleckenstein. 2001. Herpesvirus saimiri. Philos. Trans. R. Soc. Lond. B 356:545-567.
18. Gao, S.-J., Y.-J. Zhang, J.-H. Deng, C. S. Rabkin, O. Flore, and H. B. Jenson. 1999. Molecular polymorphism of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen: evidence for a large repertoire of viral genotypes and dual infection with different viral genotypes. J. Infect. Dis. 180:1466-1476.
19. Hall, K. T., M. S. Giles, D. J. Goodwin, M. A. Calderwood, A. F. Markham, and A. Whitehouse. 2000. Characterization of the herpesvirus saimiri ORF73 gene. J. Gen. Virol. 81:2653-2658.
20. Hall, K. T., M. S. Giles, D. J. Goodwin, M. A. Calderwood, I. M. Carr, A. J. Stevenson, A. F. Markham, and A. Whitehouse. 2000. Analysis of gene expression in a human cell line stably transduced with herpesvirus saimiri. J. Virol. 74:7331-7337.
21. Hart, J., M. Ackermann, G. Jayawardane, G. Russell, D. M. Haig, H. Reid, and J. P. Stewart. 2007. Complete sequence and analysis of the ovineherpesvirus 2 genome. J. Gen. Virol. 88:28-39.
22. Hochberg, D., J. M. Middeldorp, M. Catalina, J. L. Sullivan, K. Luzuriaga, and D. A. Thorley-Lawson. 2004. Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc. Natl. Acad. Sci. USA 101:239-244.
23. Karttunen, J., S. Sanderson, and N. Shastri. 1992. Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc. Natl. Acad. Sci. USA 89:6020-6024.
24. Kwun, H. J., S. Ramos da Silva, I. Shah, N. Blake, P. S. Moore, and Y. Chang. 2007. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing. J. Virol. 81:8225-8235.
25. Lomonte, P., M. Bublot, V. van Santen, G. M. Keil, P. Pastoret, and E. Thiry. 1995. Analysis of bovine herpesvirus 4 genomic regions located outside the conserved gammaherpesvirus gene blocks. J. Gen. Virol. 76:1835-1841.
26. Lee, S. P., J. M. Brooks, H. Al-Jarrah, W. A. Thomas, T. A. Haigh, G. S. Taylor, S. Humme, A. Schepers, W. Hammerschmidt, J. L. Yates, A. B. Rickinson, and N. W. Blake. 2004. CD8 T cell recognition of endogenously expressed Epstein-Barr virus nuclear antigen 1. J. Exp. Med. 199:1409-1420.
27. Leight, E. R., and B. Sugden. 2000. EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus. Rev. Med. Virol. 10:83-100.
28. Levitskaya, J., A. Sharipo, A. Leonchikis, A. Ciechanover, and M. G. Masucci. 1997. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc. Natl. Acad. Sci. USA 94:12616-12621.
29. Levitskay, J., M. Coram, V. Levitsky, S. Imreh, P. M. Steigerwald-Mullen, G. Klein, M. G. Kurilla, and M. G. Masucci. 1995. Inhibition of antigen processing by the internal repeat region of Epstein-Barr virus nuclear antigen-1. Nature 375:685-688.
30. Moore, P. S., and Y. Chang. 2001. Kaposi's sarcoma-associated herpesvirus, p. 2803-2834. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
31. + T cells by infected dendritic cells in vivo. Nat. Immunol. 3:265-271.
32. Rainbow, L., G. Platt, G. Simpson, R. Sarid, S. Gao, H. Stoiber, C. Herrington, P. Moore, and T. Schulz. 1997. The 222- to 234-kilodalton latent nuclear antigen (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by ORF73 and is a component of the latency-associated nuclear antigen. J. Virol. 71:5915-5921.
33. Rickinson, A. B., and E. Kieff. 2001. Epstein-Barr virus, p. 2575-2628. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
34. Rush, C., T. Mitchell, and P. Garside. 2002. Efficient Priming of CD4 and CD8 T cells by DNA vaccination depends on appropriate targeting of sufficient levels of immunologically relevant antigen to appropriate processing pathways. J. Immunol. 169:4951-4960.
35. Russo, J. J., R. A. Bohenzky, M. C. Chien, J. Chen, M. Yan, D. Maddalena, J. P. Parry, D. Peruzzi, I. S. Edelman, Y. Chang, and P. S. Moore. 1996. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA 93:14862-14867.
36. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbour, NY.
37. Telford, E. A. R., M. S. Watson, H. C. Aird, J. Perry, and A. J. Davison. 1995. The DNA sequence of equine herpesvirus 2. J. Mol. Biol. 249:520-528.
38. Tellam, J., C. Smith, M. Rist, N. Webb, L. Cooper, T. Vuocolo, G. Connolly, D. C. Tscharke, M. P. Devoy, and R. Khanna. 2008. Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition. Proc. Natl. Acad. Sci. USA 105:9319-9324.
39. + T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1. J. Exp. Med. 199:1421-1431.
40. + T cell epitopes. J. Exp. Med. 204:525-532.
41. Thome, M., P. Schneider, K. Hofmann, H. Fickenscher, E. Meinl, C. Neipel, C. Mattmann, K. Burns, J. L. Bodmer, M. Schroter, C. Scaffidi, P. H. Krammer, M. E. Peter, and J. Tschopp. 1997. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517-521.
42. Tscharke, D. C., G. Karupiah, J. Zhou, T. Palmore, K. R. Irvine, S. M. Mansour Haeryfar, S. Williams, J. Sidney, A. Sette, J. R. Bennink, and J. W. Yewdell. 2005. Identification of poxvirus CD8 T cell determinants to enable rational design and characterization of smallpox vaccines. J. Exp. Med. 201:95-104.
43. Verma, S. C., and E. S. Robertson. 2003. ORF73 of herpesvirus saimiri strain C488 tethers the viral genome to metaphase chromosomes and binds to cis-acting DNA sequences in the terminal repeats. J. Virol. 77:12494-12506.
44. Virgin, H. W., IV, P. Latreille, P. Wamsley, K. Hallsworth, K. E. Weck, A. J. Dal Canto, and S. H. Speck. 1997. Complete sequence and genomic analysis of murine gammaherpevirus 68. J. Virol. 71:5894-5904.
45. + T lymphocytes. J. Exp. Med. 199:459-470.
46. Yates, J., N. Warren, and B. Sugden. 1985. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313:812-815.
47. Yates, J., N. Warren, D. Reisman, and B. Sugden. 1984. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. USA 81:3806-3810.
48. Yewdell, J. W., U. Schubert, and J. R. Bennink. 2001. At the crossroads of cell biology and immunology: DRiPs and other sources of peptide ligands for MHC class I molecules. J. Cell Sci. 114:845-851.
49. Yin, Y., B. Manoury, and R. Fahraeus. 2003. Self-inhibition of synthesis and antigen presentation by the Epstein-Barr virus-encoded EBNA1. Science 301:1371-1374.
50. Zaldumbide, A., M. Ossevoort, E. J. H. J. Wietrz, and R. C. Hoeben. 2007. In cis inhibition of antigen processing by the latency-associated nuclear antigen I of Kaposi sarcoma herpes virus. Mol. Immunol. 22:1352-1360.